Our Top 5 Most Viewed Conference Video Interviews of 2024
Applied Clinical Trials sat down on-site with many KOLs at some of industry's largest gatherings in 2024 including SCOPE, DIA, and DPHARM.
Below is a list of the most viewed video interviews from Applied Clinical Trials' on-site conference coverage in 2024.
1. DIA 2024: Ginny Beakes-Read of Johnson & Johnson Discusses Regulatory Challenges
In an interview at DIA 2024, Beakes-Read, head, global regulatory policy and intelligence, Johnson & Johnson Innovative Medicine highlights the integration of technological advancements into drug development and benefits patients are seeing from FDA's Accelerated Approval Program.
Watch the interview here.
2. DPHARM 2024: Acclinate CEO Del Smith Highlights the Roles of Technology and Engagement in Clinical Research
In an interview at DPHARM 2024, Smith discusses how predictive modeling and community engagement can increase diversity.
Watch the interview here.
3. SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators
In an interview at SCOPE, Young, Chief Science Officer, CluePoints discusses where the industry is currently adopting RBQM and the level of comfort that comes with it.
Watch the interview here.
4. SCOPE 2024: YPrime CEO, Jim Corrigan Speaks About the Company and Addressing Uncertainty in Clinical Trials
In an interview at SCOPE, Corrigan discusses what YPrime is doing to address challenges in clinical trials and results from the company's recently released eCOA report.
Watch the interview here.
5. DIA 2024: Rob DiCicco of TransCelerate Biopharma Discusses the State of AI in Clinical Research
In an interview at DIA 2024, DiCicco, vice president, portfolio management, TransCelerate Biopharma highlights the use of artificial intelligence in clinical research from the perspectives of different stakeholders.
Watch the interview here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
